Sorrento Therapeutics logo
Sorrento Therapeutics SRNE
$ 0.27 -29.58%

Квартальный отчет 2023-Q1
добавлен 15.05.2023

report update icon

Sorrento Therapeutics Мультипликаторы 2011-2024 | SRNE

Мультипликаторы по годам Sorrento Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-1.4 -9.7 -1.8 -1.1 56.9 -4.3 -4.2 -7.8 -6.9 -14.7 -16.9

P/S

-4679.0 72.8 16.4 10.9 3.4 32.4 42.2 70.4 329.3 122.1 103.1

EPS

-1.4 -1.3 -2.2 -1.9 0.1 -1.2 -1.2 -1.3 -1.5 -0.0 -0.0

EV (Enterprise Value)

1.17 млрд 3.25 млрд 1.02 млрд 488 млн 724 млн 497 млн 357 млн 230 млн 146 млн 66.8 млн 51.5 млн

EBITDA per Share

-1.32 -0.859 -1.44 -1.19 0.775 -1.17 -1.32 -1.21 -0.989 -0.4 -0.311

EV/EBITDA

-3.0 -15.0 -3.8 -2.4 9.3 -3.9 -3.4 -6.5 -8.4 -14.5 -16.6

PEG

0.02 -0.24 0.12 0.0 0.51 -1.79 -0.92 -0.71 0.04 0.15 0.57

P/B

7.5 17.6 6.6 1.1 2.6 3.3 1.3 2.5 2.3 11.5 13.0

P/CF

-2.1 -14.8 -2.8 -1.9 -4.7 -3.4 -4.2 -9.2 -8.7 -16.4 -14.4

ROE %

-543.92 -180.72 -371.64 -97.17 4.58 -76.12 -31.56 -31.88 -32.80 -78.18 -76.89

ROA %

-61.65 -55.70 -52.38 -32.61 2.12 -15.17 -13.34 -24.49 -23.67 -71.45 -70.84

ROCE %

-509.79 -45.87 -44.12 -23.02 14.59 -18.40 -15.99 -26.16 -18.00 -78.30 -77.03

Current Ratio

1.1 0.9 0.6 2.9 0.4 1.2 4.6 7.7 6.0 9.0 9.9

DSO

-49566.1 141.5 168.5 75.1 9.4 133.7 208.2 69.9 312.7 49.9 42.2

DIO

- 67.2 100.3 - - - - - - - -

DPO

- 907.2 824.1 714.3 917.0 3727.4 250.6 295.9 177064.5 - -

Операционный цикл

-49566.1 208.8 268.8 75.1 9.4 133.7 208.2 69.9 312.7 - -

Финансовый цикл

-49566.1 -698.4 -555.3 -639.3 -907.6 -3593.8 -42.4 -226.0 -176751.7 - -

Все данные представлены в валюте USD

Мультипликаторы поквартально Sorrento Therapeutics

2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.26 - -0.2 -0.54 -0.12 -0.47 -0.4 -0.57 0.01 -0.27 -0.33 -0.36 -0.36 -0.41 -0.49 -0.46 -0.88 -0.41 -0.4 -0.73 -0.38 0.6 -0.03 -0.2 -0.45 -0.3 0.24 -0.93 -0.41 -0.62 -0.03 -0.3 -0.29 -0.26 -0.27 -0.33 -0.44 - -0.24 -0.35 -0.2 - -0.1 -0.08 - - - - -

EBITDA per Share

-0.19 - -0.22 -0.28 -0.31 - -0.31 -0.33 -0.29 - -0.3 -0.19 -0.22 - -0.34 -0.36 -0.98 - -0.36 -0.24 -0.36 - 1.33 -0.15 -0.43 - -0.17 -0.94 -0.57 - -905 -0.25 -0.26 - -0.17 -254 -395 - -0.19 -0.33 -0.2 - -0.09 -0.07 - - - - -

ROE %

-186.29 -247.65 -431.04 -454.32 -382.51 -363.42 -223.32 -182.97 -140.20 -180.72 -217.36 -248.45 -273.60 -371.64 -315.47 -256.10 -219.13 -97.17 -49.13 -27.57 0.58 4.58 -42.01 -21.12 -68.12 -76.12 -72.13 -92.63 -46.07 -33.71 -23.21 -29.56 -29.79 -31.88 -29.08 -27.11 -52.13 -70.62 -148.80 -221.96 -267.34 -170.99 -187.67 -126.17 -73.83 -58.78 -16.68 -25.84 -16.26

ROA %

-94.17 -54.04 -74.83 -76.19 -62.87 -57.71 -50.27 -50.03 -43.14 -55.70 -53.62 -49.49 -45.16 -52.38 -49.09 -45.12 -46.77 -32.61 -13.41 -6.31 2.24 2.12 -13.56 -9.12 -16.62 -15.17 -18.47 -22.70 -15.10 -14.24 -12.51 -17.61 -20.39 -24.49 -22.10 -20.35 -38.05 -50.96 -122.41 -190.23 -238.01 -156.26 -171.63 -115.55 -67.91 -54.16 -15.37 -23.81 -14.98

ROCE %

-168.46 -217.44 -294.64 -288.84 -255.85 -168.17 -218.49 -191.61 -166.31 -105.36 -173.16 -190.64 -225.82 -288.61 -311.48 -266.55 -216.01 -51.95 -3.39 68.05 74.85 30.13 14.83 -49.04 -98.16 -98.67 -123.22 -132.47 -83.86 -38.82 -45.38 -27.39 -27.48 -22.99 -27.94 -26.33 -26.04 -15.77 -35.84 -50.95 -59.13 -49.95 -66.67 -63.32 -73.96 -58.89 -16.72 -25.88 -16.30

Current Ratio

0.8 1.0 1.3 1.3 1.4 1.1 1.2 1.3 1.6 1.4 1.4 1.4 1.4 1.1 1.1 1.1 1.1 1.5 1.5 1.5 1.5 1.9 1.9 1.9 1.9 1.3 1.3 1.3 1.3 1.7 1.7 1.7 1.7 4.3 4.3 4.3 - - - - - - - - - - - - -

DSO

143.2 - 35988.6 31296.8 107.7 122.7 10819.5 -80353.9 -3464.3 123.0 -2499.9 -301.1 -2458.5 91.1 168.6 121.1 83.5 40.2 67.9 89.4 44.1 9.9 1.6 43.2 36.6 38.5 69.0 171.6 120.0 61.6 74.7 70.2 76.3 83.7 52.4 86.2 52.6 - 433.2 253.2 161.3 - - - - - - - -

DIO

- - - - - - - - - - - - - - - 93.5 123.8 - 121.5 215.7 100.9 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - 768.4 819.3 - 579.1 1028.4 825.8 - 833.5 1108.3 780.1 - 1808.0 2561.8 1222.7 - 202.3 389.1 268.5 - 286.7 296.3 308.7 - - - - - - - - - - - -

Операционный цикл

143.2 - 35988.6 31296.8 107.7 122.7 10819.5 -80353.9 -3464.3 123.0 -2499.9 -301.1 -2458.5 91.1 168.6 214.6 207.2 40.2 189.4 305.1 145.0 9.9 1.6 43.2 36.6 38.5 69.0 171.6 120.0 61.6 74.7 70.2 76.3 83.7 52.4 86.2 52.6 - 433.2 253.2 161.3 - - - - - - - -

Финансовый цикл

143.2 - 35988.6 31296.8 107.7 122.7 10819.5 -80353.9 -3464.3 123.0 -2499.9 -301.1 -2458.5 91.1 168.6 -553.8 -612.1 40.2 -389.8 -723.3 -680.8 9.9 -831.9 -1065.1 -743.6 38.5 -1739.0 -2390.2 -1102.7 61.6 -127.6 -318.9 -192.1 83.7 -234.4 -210.1 -256.0 - 433.2 253.2 161.3 - - - - - - - -

Все данные представлены в валюте USD